HIV treatment series. Part 4 of 4. Decisions, decisions--starting or switching anti-HIV therapy

Steve McGuire. Posit Aware. 2003 May-Jun.

. 2003 May-Jun;14(3):31-6.

No abstract available

Similar articles

Switching antiretroviral therapy: why, when and how.
Wilkin T, Glesby M, Gulick RM. Wilkin T, et al. IAPAC Mon. 2006 Jul;12(7):220-9. IAPAC Mon. 2006. PMID: 17096494 No abstract available.
To start or not to start?
Learned J. Learned J. Posit Aware. 2001 Sep-Oct;12(5):28-9. Posit Aware. 2001. PMID: 11688482 No abstract available.
Third line anti-HIV therapy options.
[No authors listed] [No authors listed] Proj Inf Perspect. 2004 Jan;(37):19-21. Proj Inf Perspect. 2004. PMID: 15119286
Drugs for HIV infection.
[No authors listed] [No authors listed] Treat Guidel Med Lett. 2011 Jun;9(106):29-40. Treat Guidel Med Lett. 2011. PMID: 21617596 Review. No abstract available.
[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida. Panel de expertos de Gesida y Plan Nacional sobre el Sida. Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.